Lyme disease vaccine - MedImmuneAlternative Names: MEDI 490; rBCG-OspA
Latest Information Update: 07 Jun 2000
At a glance
- Originator MedImmune
- Class Bacterial vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Lyme disease
Most Recent Events
- 07 Jun 2000 New profile, split from generic Lyme disease vaccine profile
- 19 Jan 2000 Discontinued-I for Lyme disease in USA (Parenteral)